The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection
- PMID: 31130328
- DOI: 10.1016/S1473-3099(19)30054-4
The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection
Comment on
-
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.Lancet Infect Dis. 2019 Jul;19(7):728-739. doi: 10.1016/S1473-3099(18)30804-1. Epub 2019 May 23. Lancet Infect Dis. 2019. PMID: 31130329 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
